BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17704717)

  • 1. Cyclin D1 expression and histopathologic features in vestibular schwannomas.
    Lassaletta L; Patrón M; Del Río L; Alfonso C; Roda JM; Rey JA; Gavilan J
    Otol Neurotol; 2007 Oct; 28(7):939-41. PubMed ID: 17704717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D(1) and D(3) expression in vestibular schwannomas.
    Neff BA; Oberstien E; Lorenz M; Chaudhury AR; Welling DB; Chang LS
    Laryngoscope; 2006 Mar; 116(3):423-6. PubMed ID: 16540902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
    Fisher LM; Doherty JK; Lev MH; Slattery WH
    Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vestibular schwannoma volume as a predictor of hearing outcome after surgery.
    Gjuric M; Mitrecic MZ; Greess H; Berg M
    Otol Neurotol; 2007 Sep; 28(6):822-7. PubMed ID: 17554228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoblastoma-cyclin-dependent kinase pathway deregulation in vestibular schwannomas.
    Lasak JM; Welling DB; Akhmametyeva EM; Salloum M; Chang LS
    Laryngoscope; 2002 Sep; 112(9):1555-61. PubMed ID: 12352662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sudden hearing loss induced by acoustic neuroma: significance of small tumors.
    Yanagihara N; Asai M
    Laryngoscope; 1993 Mar; 103(3):308-11. PubMed ID: 8441318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanotic nonpsammomatous trigeminal schwannoma as the first manifestation of Carney complex: case report.
    Carrasco CA; Rojas-Salazar D; Chiorino R; Venega JC; Wohllk N
    Neurosurgery; 2006 Dec; 59(6):E1334-5; discussion E1335. PubMed ID: 17277668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
    Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
    Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous deregulation of p16 and cyclin D1 genes in pancreatic ductal adenocarcinoma: a combined immunohistochemistry and image analysis study based on tissue microarrays.
    Tsiambas E; Karameris A; Gourgiotis S; Salemis N; Athanassiou AE; Karakitsos P; Papalois A; Merikas E; Kosmidis P; Patsouris E
    J BUON; 2007; 12(2):261-7. PubMed ID: 17600882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelioid schwannoma of the vestibular nerve.
    Tan TC; Lam PW
    Singapore Med J; 2004 Aug; 45(8):393-6. PubMed ID: 15284935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D1 expression and facial function outcome after vestibular schwannoma surgery.
    Lassaletta L; Del Rio L; Torres-Martin M; Rey JA; Patrón M; Madero R; Roda JM; Gavilan J
    Otol Neurotol; 2011 Jan; 32(1):136-40. PubMed ID: 21131888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are stage IV vestibular schwannomas preoperatively different from other stages?
    Tringali S; Dubreuil C; Zaouche S; Ferber-Viart C
    Otol Neurotol; 2008 Jan; 29(1):46-9. PubMed ID: 18046259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A non-NF2 case of schwannomas of vestibular and trigeminal nerves with different genetic alterations of NF2 gene: case report.
    Kambe A; Kamitani H; Watanabe T; Oka A; Inagaki H; Ishii T; Ueki K
    Surg Neurol; 2005 Jan; 63(1):62-4; discussion 64-5. PubMed ID: 15639530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive vestibular schwannomas with postoperative rapid growth: clinicopathological analysis of 15 cases.
    Hwang SK; Kim DG; Paek SH; Kim CY; Kim MK; Chi JG; Jung HW
    Neurosurgery; 2002 Dec; 51(6):1381-90; discussion 1390-1. PubMed ID: 12445343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracanalicular facial nerve schwannoma.
    Park HY; Kim SH; Son EJ; Lee HK; Lee WS
    Otol Neurotol; 2007 Apr; 28(3):376-80. PubMed ID: 17414044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve of origin, tumor size, hearing preservation, and facial nerve outcomes in 359 vestibular schwannoma resections at a tertiary care academic center.
    Jacob A; Robinson LL; Bortman JS; Yu L; Dodson EE; Welling DB
    Laryngoscope; 2007 Dec; 117(12):2087-92. PubMed ID: 17921903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. False-positive magnetic resonance imaging in the diagnosis of vestibular schwannoma.
    House JW; Bassim MK; Schwartz M
    Otol Neurotol; 2008 Dec; 29(8):1176-8. PubMed ID: 18800020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cyclins D1 and D3 in vestibular schwannoma.
    Jabbour J; Earls P; Biggs N; Gracie G; Fagan P; Bova R
    J Laryngol Otol; 2016 Jan; 130 Suppl 1():S2-10. PubMed ID: 26165351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of intracochlear schwannomas.
    Grayeli AB; Fond C; Kalamarides M; Bouccara D; Cazals-Hatem D; Cyna-Gorse F; Sterkers O
    Otol Neurotol; 2007 Oct; 28(7):951-7. PubMed ID: 17728691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening patients with sensorineural hearing loss for vestibular schwannoma using a Bayesian classifier.
    Nouraei SA; Huys QJ; Chatrath P; Powles J; Harcourt JP
    Clin Otolaryngol; 2007 Aug; 32(4):248-54. PubMed ID: 17651265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.